Details for New Drug Application (NDA): 202071
✉ Email this page to a colleague
The generic ingredient in POLYETHYLENE GLYCOL 3350 is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
Summary for 202071
Tradename: | POLYETHYLENE GLYCOL 3350 |
Applicant: | Elysium |
Ingredient: | polyethylene glycol 3350 |
Patents: | 0 |
Pharmacology for NDA: 202071
Mechanism of Action | Osmotic Activity |
Physiological Effect | Stimulation Large Intestine Fluid/Electrolyte Secretion |
Suppliers and Packaging for NDA: 202071
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 202071 | ANDA | WALGREEN COMPANY | 0363-5260 | 0363-5260-07 | 119 g in 1 BOTTLE, PLASTIC (0363-5260-07) |
POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 202071 | ANDA | WALGREEN COMPANY | 0363-5260 | 0363-5260-14 | 238 g in 1 BOTTLE, PLASTIC (0363-5260-14) |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | FOR SOLUTION;ORAL | Strength | 17GM/SCOOPFUL | ||||
Approval Date: | Dec 28, 2012 | TE: | RLD: | No |
Complete Access Available with Subscription